Laboratory and Field Evaluation of the Crystal VC-O1 Cholera Rapid Diagnostic Test.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
05 04 2021
Historique:
received: 29 09 2020
accepted: 22 01 2021
pubmed: 6 4 2021
medline: 27 1 2022
entrez: 5 4 2021
Statut: epublish

Résumé

Cholera is a severe acute, highly transmissible diarrheal disease which affects many low- and middle-income countries. Outbreaks of cholera are confirmed using microbiological culture, and additional cases during the outbreak are generally identified based on clinical case definitions, rather than laboratory confirmation. Many low-resource areas where cholera occurs lack the capacity to perform culture in an expeditious manner. A simple, reliable, and low-cost rapid diagnostic test (RDT) would improve identification of cases allowing rapid response to outbreaks. Several commercial RDTs are available for cholera testing with two lines to detect either serotypes O1 and O139; however, issues with sensitivity and specificity have not been optimal with these bivalent tests. Here, we report an evaluation of a new commercially available cholera dipstick test which detects only serotype O1. In both laboratory and field studies in Kenya, we demonstrate high sensitivity (97.5%), specificity (100%), and positive predictive value (100%) of this new RDT targeting only serogroup O1. This is the first field evaluation for the new Crystal VC-O1 RDT; however, with these high-performance metrics, this RDT could significantly improve cholera outbreak detection and improve surveillance for better understanding of cholera disease burden.

Identifiants

pubmed: 33819171
doi: 10.4269/ajtmh.20-1280
pii: tpmd201280
pmc: PMC8176501
doi:
pii:

Substances chimiques

Reagent Kits, Diagnostic 0

Types de publication

Evaluation Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2017-2023

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI123422
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI175214
Pays : United States

Auteurs

Amanda K Debes (AK)

1Department of International Health, Johns Hopkins School of Public Health, Baltimore, Maryland.

Kelsey N Murt (KN)

1Department of International Health, Johns Hopkins School of Public Health, Baltimore, Maryland.

Ethel Waswa (E)

2Ministry of Health, Nairobi, Kenya.

Gerald Githinji (G)

2Ministry of Health, Nairobi, Kenya.

Mamo Umuro (M)

2Ministry of Health, Nairobi, Kenya.

Caroline Mbogori (C)

2Ministry of Health, Nairobi, Kenya.

Mellisa Roskosky (M)

1Department of International Health, Johns Hopkins School of Public Health, Baltimore, Maryland.

Malathi Ram (M)

1Department of International Health, Johns Hopkins School of Public Health, Baltimore, Maryland.

Allison Shaffer (A)

1Department of International Health, Johns Hopkins School of Public Health, Baltimore, Maryland.

David A Sack (DA)

1Department of International Health, Johns Hopkins School of Public Health, Baltimore, Maryland.

Waqo Boru (W)

2Ministry of Health, Nairobi, Kenya.
3Field Epidemiology and Laboratory Training Program, Nairobi, Kenya.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH